Literature DB >> 7730870

The association of waist/hip ratio with diabetes complications in an adult IDDM population.

W L Stuhldreher1, D J Becker, A L Drash, D Ellis, L H Kuller, S K Wolfson, T J Orchard.   

Abstract

Cross-sectional data from the Epidemiology of Diabetes Complications Study were used to examine the relationships between waist to hip circumference ratio (WHR) and the presence of diabetes complications in IDDM adults ages 18-45 years (N = 586). Significantly higher WHRs were observed among both genders with proliferative retinopathy or peripheral vascular disease and only among males with either neuropathy or nephropathy compared to those free of these complications. Logistic regression to determine the strength of association between WHR and each complication demonstrated that although WHR was significantly related to each complication (except nephropathy among females), WHR was only independently related to neuropathy in males and PVD in females in the final model when hypertension, LDL- and HDL-cholesterol and fibrinogen were included. These findings suggest that WHR acts as a marker of risk for diabetes complications mainly through an influence on other complication risk factors.

Entities:  

Mesh:

Year:  1994        PMID: 7730870     DOI: 10.1016/0895-4356(94)90291-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes.

Authors:  Shalamar D Sibley; Ian H de Boer; Michael W Steffes; John D Brunzell
Journal:  Diabetes Care       Date:  2007-04-24       Impact factor: 19.112

2.  Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

Authors:  Ian H de Boer; Shalamar D Sibley; Bryan Kestenbaum; Joshua N Sampson; Bessie Young; Patricia A Cleary; Michael W Steffes; Noel S Weiss; John D Brunzell
Journal:  J Am Soc Nephrol       Date:  2006-12-06       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.